James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 40,488 shares at $4.97 ($205K) on 2022-01-19, disclosed to the SEC on 2022-01-21.
Open-market purchase of $205k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.97 | 10,244 | $51K | 24.8% |
| 2 | $4.97 | 10,244 | $51K | 24.8% |
| 3 | $5.17 | 20,000 | $103K | 50.4% |
| Total | $5.07 avg | 40,488 | $205K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |